Vaccinology and applied Microbiology
Vaccination is the most efficient strategy to prevent infectious diseases. The art of the vaccine researcher lies in finding substances that prevent us from falling ill with diseases such as influenza or viral hepatitis. But what makes a vaccine successful and ensures effective protection? Our scientists study the reaction of the immune system to answer that question – and to develop better vaccination strategies.
Leader
Technology Offers
The Mucosal Adjuvant Platform of the HZI Department of Vaccinology, provides expertise, technology and infrastructure in the fields of adjuvants, immune modulators and formulation, including mucosal adjuvants. Our experts in mucosal vaccine delivery have established in vitro and in vivo models to assess the activity of adjuvants and vaccine formulations on innate and adaptive immune cells, as well their capacity to stimulate different clearance effector mechanisms. The team has access to state-of-the-art laboratories and animal facilities with BSL2 and BSL3 containment, flow cytometry and sorting facilities and in vivo imaging (IVIS).
The HZI Department of Vaccinology provides mucosal adjuvants and advanced immune monitoring and consulting services for the vaccine community worldwide (academic and industry), including advanced immune system monitoring (e.g. 13 colour multiparametric analysis by flow cytometry, in vivo CTL assays) and biomarkers.
News
Bachelor & Master
Are you interested in a bachelor or master thesis? We are looking forward to your request!